I

India Glycols Limited

INDIAGLYCONSE
Market snapshot · 2026-08-11 10:53 UTC

1,073.10

₹-11.70 (-1.08%)

MARKET CAP

₹7.19K Cr

STOCK P/E

24.6x

52W HIGH

₹1,222.00

52W LOW

₹792.50

BOOK VALUE

₹437.55

EPS

₹43.61

ROE

11.28%

SECTOR

Materials

DEBT/EQUITY

57.65

VOLUME

1.64L

P/B RATIO

2.45x

PEG RATIO

Sector

Materials

Themes

Commodity Chemicals
D
Dividend
S
Split
₹1,159.30₹1,068.31₹977.32₹886.32₹795.33VolumeSDDAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

India Glycols is a materials company manufacturing bio-based specialities and performance chemicals. Bio-based glycols, specialty chemicals, and biofuels including ethanol, DDGS, and DWGS drive its core revenue mix. Potable spirits and Ennature Biopharma provide additional operating segments. No major recent development changes the near-term growth or margin outlook. Revenue rose 11.8% year-on-year, while profit increased 26.8%. Stable margins and 11.3% ROE indicate consistent profitability, though debt-to-equity of 57.65 materially amplifies financial leverage and affects equity returns. The company’s portfolio spans biopolymers, brake fluids, bioamines, MDEA derivatives, and molasses- and grain-based products. At 24.9 times earnings, valuation appears fair relative to current growth, rather than clearly discounted. Investor focus remains on whether biofuel and specialty-chemical growth can offset leverage-related risk.

Valuation Metrics

Trading 64.8% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.51). Confidence: 63%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

13.13

Current

24.61

Overvalued

21.35

Undervalued

9.93

EV/EBITDA
Strongly Overvalued

5Y Average

7.58

Current

14.20

Overvalued

10.77

Undervalued

4.90

P/B
Undervalued

5Y Average

2.54

Current

2.45

Overvalued

2.92

Undervalued

2.16

Peers & Comparison

Sector: Materials · Theme: Commodity Chemicals

Commodity Chemicals Peers5 peers
Avg P/E: 46.4x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
RAIN INDUSTRIES LIMITED
RAINCommodity Chemicals
+20.0%1.7%
24.7x
Undervalued
-47% vs avg
+29.4%
PCBL CHEMICAL LIMITED
PCBLCommodity Chemicals
+17.0%3.0%
48.6x
Fair
+5% vs avg
-16.1%
GULF OIL LUB. IND. LTD.
GULFOILLUBCommodity Chemicals
+30.6%8.6%
15.3x
Undervalued
-67% vs avg
+2.5%
RAGHAV PRODUCTIVITY ENH L
RPELCommodity Chemicals
+48.7%22.0%
95.0x
Premium
+105% vs avg
+109.9%
GARWARE HI-TECH FILMS LTD
GRWRHITECHCommodity Chemicals
+31.9%17.1%
48.2x
Fair
+4% vs avg
+144.1%
WHY THESE PEERS

INDIA GLYCOLS LTD trades at a discount (24.3x vs peer avg 46.4x), suggesting potential undervaluation relative to the Commodity Chemicals cohort. Peers include RAIN INDUSTRIES LIMITED, PCBL CHEMICAL LIMITED, GULF OIL LUB. IND. LTD. — selected based on business model, industry classification, market cap similarity, and business theme alignment.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹978 CrMar 2026

Latest net profit

₹110 CrMar 2026

Latest EPS

₹16.45Mar 2026

Net margin

17.0%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%5.0%10.0%15.0%20.0%0.00 Cr300 Cr600 Cr900 Cr1.20K Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr300 Cr600 Cr900 Cr1.20K Cr₹0₹5₹10₹15₹20
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr250 Cr500 Cr750 Cr1.00K Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-2.50K Cr0.00 Cr2.50K Cr5.00K Cr7.50K Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6196887759049249689619758631,0401,0911,102978
Expenses +522592681801818846845851719893932926814
Operating Profit979594103105123116124144148158176164
OPM %16%14%12%11%11%13%12%13%17%14%14%16%17%
Other Income +461155346212-039
Interest26282931333640444545494726
Depreciation29212826262828273334384141
Profit before tax465348505162535868707288136
Tax %13%24%25%24%26%25%26%25%26%25%26%26%19%
Net Profit +404136383847394450535465110
EPS in Rs6.486.555.766.116.107.556.377.088.138.548.719.7416.45
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +61.02%61.02%59.63%59.63%59.63%
FIIs +3.44%2.62%2.42%2.27%2.24%
DIIs +1.39%1.34%5.22%5.19%5.21%
Public +34.15%35.04%32.72%32.91%32.91%
Others0.01%0.01%
Jun 2026
Promoters +
FIIs +
DIIs +
Public +
Others

Events Timeline

Annual Report FY26

FY2026PDFCompany Reports Open

Intimation Of Q1FY27 Earnings Conference Call

Aug 06, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Aug 06, 2026PDFCompany Reports Open

Closure of Trading Window

Aug 05, 2026PDFCompany Reports Open

Board Meeting Intimation for Consider And Approve The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The First Quarter Ended 30Th June, 2026.

Aug 05, 2026PDFCompany Reports Open